Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P30044 (
antioxidant enzyme
)
8,037
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Methionine sulfoxide reductase
(
MSRA
) is an
antioxidant enzyme
implicated in protection against oxidative stress and protein maintenance. We have previously reported the association of marker D8S542, located within the
MSRA
gene, with schizophrenia in the Central Valley of Costa Rica (CVCR). By performing fine mapping analysis, we have now identified a potential three-marker at risk haplotype within
MSRA
in the same CVCR sample, with a global P-value slightly above nominal significance (P = 0.0526). By sequencing the
MSRA
gene in individuals carrying this haplotype, we identified a novel 4-base pair deletion 1,792 bases upstream of the
MSRA
transcription start site. This deletion was significantly under-transmitted to schizophrenia patients in the CVCR sample (P = 0.0292) using FBAT, and this was replicated in a large independent sample of 321 schizophrenia families from the Hispanic population (P = 0.0367). These findings suggest a protective effect of the deletion against schizophrenia. Further,
MSRA
mRNA levels were significantly lower in lymphoblastoid cell lines of individuals homozygous for the deletion compared to carriers of the normal allele (P = 0.0135), although significance was only evident when genotypes were collapsed. This suggests that the deleted sequence may play a role in regulating
MSRA
expression. In conclusion, this work points towards
MSRA
as a novel schizophrenia candidate gene. Further studies into the mechanisms by which
MSRA
is involved in schizophrenia pathophysiology may shed light into the biological underpinnings of this disorder.
...
PMID:Methionine sulfoxide reductase: a novel schizophrenia candidate gene. 1850 7
The essential mechanisms and virulence factors enabling Francisella species to replicate inside host macrophages are not fully understood.
Methionine sulfoxide reductase
(Msr) is an
antioxidant enzyme
that converts oxidized methionine into methionine. Francisella tularensis carries msrA and msrB in different parts of its chromosome. In this study, single and double mutants of msrA and msrB were constructed, and the characteristics of these mutants were investigated. The msrB mutant exhibited decreased in vitro growth, exogenous oxidative stress resistance and intracellular growth in macrophages, whereas the msrA mutant displayed little difference with wild-type strain. The double mutant exhibited the same characteristics as the msrB mutant. The bacterial count of the msrB mutant was significantly lower than that of the wild-type strain in the liver and spleen of mice. The bacterial count of the msrA mutant was lower than that of the wild-type strain in the liver, but not in the spleen, of mice. These results suggest that MsrB has an important role in the intracellular replication of F. tularensis in macrophages and infection in mice.
...
PMID:Contribution of methionine sulfoxide reductase B (MsrB) to Francisella tularensis infection in mice. 2810 83